Rosuvastatin Completed Phase 4 Trials for Ischemia Reperfusion Injury Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00457652Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?